FDA Drug Shortage Database
Hydrochlorothiazide and quinapril (Accuretic) shortage
The FDA Drug Shortage Database lists 3 of 6 hydrochlorothiazide and quinapril presentations as limited or unavailable (updated October 2, 2026); the first entry was posted on January 19, 2023. 3 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 22.5mg tablet | 1 | 1 | 0 |
| 32.5mg tablet | 1 | 1 | 0 |
| 45mg tablet | 1 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
Listed now, available (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
| Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Lisinopril | High blood pressure | No current entry | 36 labelers | $0.0254 per tablet 20 mg tablet |
| Enalapril | High blood pressure | No current entry | 28 labelers | $0.0664 per tablet 10 mg tablet |
| Amlodipine and benazepril | High blood pressure | No current entry | 16 labelers | $0.114 per unit 10-20 mg |
| Benazepril | High blood pressure | No current entry | 21 labelers | $0.0789 per tablet 20 mg tablet |
| Ramipril | High blood pressure | No current entry | 17 labelers | $0.0707 per capsule 10 mg capsule |
| Captopril | High blood pressure | No current entry | 13 labelers | $0.228 per tablet 12.5 mg tablet |
| Fosinopril | High blood pressure | No current entry | 7 labelers | $0.154 per tablet 10 mg tablet |
| Trandolapril | High blood pressure | No current entry | 5 labelers | $0.157 per tablet 1 mg tablet |
| Trandolapril and verapamil | High blood pressure | No current entry | 1 labeler | n/a |
| Perindopril | High blood pressure | No current entry | 1 labeler | $0.495 per tablet 4 mg tablet |
| Chlorothiazide | High blood pressure | A presentation being discontinued | 5 labelers | n/a |
| Metoprolol | High blood pressure | A presentation being discontinued | 74 labelers | $0.085 per tablet 100 mg tablet |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage